Effectiveness of a 26-week glucocorticoid taper in giant cell arteritis treated with tocilizumab in real-world clinical practice: a single-centre cohort study
In this real-world setting, 26- and 16-week GC tapers were effective and safe in patients with newly diagnosed GCA treated with TCZ.
Authors
- Florian Günther (ORCID: https://orcid.org/0000-0001-9951-1748)
- Martin Fleck (ORCID: https://orcid.org/0000-0002-0187-6632)
- Georg Pongratz (ORCID: https://orcid.org/0000-0002-2185-8458)
- Stefan Löffler
- Wolfgang Hartung (ORCID: https://orcid.org/0000-0001-9158-3616)
Institutions
- University Hospital Regensburg (DE)
- Asklepios Kliniken Bad Abbach (DE)
- Krankenhaus Barmherzige Brüder (DE)
- University of Regensburg (DE)
Publication Details
- Journal
- Rheumatology Advances in Practice
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/rap/rkaf081
- Citations
- 1
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.52